LGALS3 and neoplasm: This discrepancy was likely due to differing sample size, histologies, or antibodies etc. Moreover, some studies focused on Gal3 expression in only tumor cells of either the primary and or metastatic lesions, while others focused on the stroma expression [16, 18].